Sustained Ventricular Tachycardia as the first presentation of transthyretin amyloid cardiomyopathy. [PDF]
Rev Fac Cien Med Univ Nac CordobaRamos HR +11 more
europepmc +1 more source
Disease-Modifying Therapies for Transthyretin Amyloid Cardiomyopathy: A Systematic Review and Meta-Analysis. [PDF]
Arq Bras CardiolFacin LC +9 more
europepmc +1 more source
Unraveling the Challenges in Diagnosing Cardiac Amyloidosis. [PDF]
Arq Bras CardiolCapeline LS.
europepmc +1 more source
Características clínicas y manejo de pacientes con amiloidosis cardiaca en la práctica clínica: análisis de una cohorte de 33 pacientes. [PDF]
Arch Cardiol MexJiménez-Azzaoui B +5 more
europepmc +1 more source
Aducanumab: A look two years after its approval [PDF]
BiomedicaTorres A, Camargo L, López N.
europepmc +1 more source
Monoclonal gammopathy progressing to systemic amyloidosis with cardiac involvement. A case report. [PDF]
Arch Peru Cardiol Cir CardiovascValenzuela-Rodríguez G +2 more
europepmc +1 more source
Angiopatía amiloide cerebral: fisiopatología y estrategias terapéuticas.
Universidad de Sevilla. Grado en Bioquímica por la Universidad de Sevilla y Universidad de Málaga.
openaire +2 more sources
Does Secondary HFpEF Exist? Yes, but it Should not be Called HFpEF. [PDF]
Arq Bras CardiolVillacorta H, Schwartzmann P.
europepmc +1 more source
Physiopathological mechanisms underlying Alzheimer's disease: a narrative review. [PDF]
Dement NeuropsycholEngelhardt E, Resende EPF, Gomes KB.
europepmc +1 more source
Agregació del pèptid β-amiloïde i immunoteràpia per la malaltia d'Alzheimer [PDF]
, 2013 Lorenzo Sanz, Laura +1 more
core